Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether enoxaparin (an anticoagulant) is effective
in the treatment of patients presenting to the emergency room with chest pain and no
electrocardiogram or bloodwork evidence of a heart attack, but with other high risk clinical
features